Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9877616 | 0.71 | POLB (0.41) | CA2NISCH | |
| SCHEMBL30539313 | 0.71 | CA2 (0.40) | CA2NISCHATMHTR1AADRA2A | |
| SCHEMBL3205767 | 0.71 | CA2 (0.40) | CA2NISCHATMHTR1AADRA2A | |
| SCHEMBL329447 | 0.66 | MAOA (0.46) | CA2NISCHHTR1AADRA2ADRD1 | |
| SCHEMBL23894634 | 0.64 | MAOA (0.35) | ATM | |
| SCHEMBL23219887 | 0.63 | LTA4H (0.31) | — | |
| SCHEMBL1890902 | 0.60 | NISCH (0.53) | CA2NISCHHTR1AADRA2ADRD1 | |
| SCHEMBL406201 | 0.60 | LTA4H (0.36) | CA2NISCHATM | |
| SCHEMBL437597 | 0.60 | CA2 (0.50) | CA2NISCH | |
| SCHEMBL312107 | 0.60 | ABCG2 (0.36) | CA2NISCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10978647-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10978647-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLCO2A1, SLC25A21 | CA2 1936/4885NISCH 1031/4885ATM 4534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.